Rituximab Plus CHOP Followed by Maintenance Rituximab as Initial Therapy for Aggressive Non-Hodgkin's Lymphoma (NHL); Initial Results of Induction Therapy, Including Rituximab Pharmacokinetics, in a Phase II Study.
| Autor: | Huang, Jane E., Saleh, Alfred *, Lee, J. Thomas *, Langmuir, Virginia *, Zhang, Fan *, Hainsworth, John |
|---|---|
| Zdroj: | In Blood 16 November 2004 104(11):4616-4616 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|